PHARMACOLOGICAL REGULATION OF NGF BIOSYNTHESIS

NGF生物合成的药理学调控

基本信息

批准号：
2259729
负责人：
Italo Mocchetti
金额：
$ 6.75万
依托单位：
GEORGETOWN UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1993
资助国家：
美国
起止时间：
1993-08-01 至 1998-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/2259729
关键词：
PC12 cells aging beta adrenergic receptor cerebral cortex choline acetyltransferase cholinergic receptors cyclic AMP dexamethasone dihydrotestosterone enzyme induction /repression genetic enhancer element genetic promoter element glioma growth factor receptors hormone regulation /control mechanism laboratory rat neuropharmacology neurotrophic factors norepinephrine protein biosynthesis protein kinase C receptor expression tissue /cell culture transcription factor

PC12 cells aging beta adrenergic receptor cerebral cortex choline acetyltransferase cholinergic receptors cyclic AMP dexamethasone dihydrotestosterone enzyme induction /repression genetic enhancer element genetic promoter element glioma growth factor receptors hormone regulation /control mechanism laboratory rat neuropharmacology neurotrophic factors norepinephrine protein biosynthesis protein kinase C receptor expression tissue /cell culture transcription factor

展开

项目摘要

We have demonstrated that the activation of beta-adrenergic receptors (BAR) by the lipophilic BAR agonist clenbuterol increases NGF biosynthesis in rat cerebral cortex and in C6-2B glioma cells (glial phenotype). The increase in NGF mRNA is due to increased gene expression. I will extend these studies by using various BAR agonists and antagonists (acute or protracted treatments) in adult and 2 year old rats. Neuroanatomical correlates will be used to establish whether NGF, induced pharmacologically, exerts physiological effects. C6-2B rat glioma cells will be used to characterize signal transduction mechanisms (activation of protein kinases A and C) and steroid receptors operative in the regulation of NGF biosynthesis in glial cells. These studies will be complemented by experiments aimed to test whether transcriptional factors which contribute to the tissue specific regulation of NGF expression, are induced or activated (following the proposed pharmacological manipulations) in glial and/or neuronal cells.

我们已经证明了β-肾上腺素能受体的激活（bar）由亲脂性棒激动剂clenbuterol增加NGF 大鼠脑皮质和C6-2B神经胶质瘤细胞中的生物合成（神经胶质表型）。 NGF mRNA的增加是由于基因增加表达。我将通过使用各种酒吧激动剂来扩展这些研究成人和2岁的拮抗剂（急性或长期治疗）老鼠。神经解剖学相关性将用于确定NGF是否诱导的药理学会发挥生理作用。 C6-2B大鼠神经胶质瘤细胞将用于表征信号转导机制（蛋白激酶A和C的激活）和类固醇受体的手术在调节神经胶质细胞中NGF生物合成的过程中。这些研究会通过旨在测试转录的实验补充有助于组织特异性调节NGF的因素表达，诱导或激活（遵循提出的在神经胶质和/或神经元细胞中的药理操作）。